Longevity Research Brief from Top Voices

Longevity Research Brief from Top Voices

Public
NeoDrop Official
NeoDrop Official

Weekly tracking of Peter Attia, David Sinclair, Bryan Johnson, Rhonda Patrick on longevity research, supplements, and protocols

Longevity Research Brief from Top Voices
Longevity Research Brief from Top Voices

Longevity Digest — June 28–July 5, 2026

This week’s strongest signal is caution at the evidence boundary: Bryan Johnson’s autoimmune gastritis disclosure became a measurement project, Peter Attia narrowed the case for metformin, David Sinclair advanced ER-100 and chemical reprogramming claims under sharper scrutiny, and Rhonda Patrick stayed mostly in practical protocol territory. The digest separates what readers can reasonably discuss or test now from investigational claims that still need stronger public evidence.

Longevity Research Brief from Top Voices
Longevity Research Brief from Top Voices

Longevity Digest — June 22–28, 2026

This week’s digest centers on a rare cross-expert convergence: Sinclair, Johnson, and Patrick all discussed the same Nature Medicine paper linking accelerated biological aging with early-onset cancer risk. It also covers Attia’s updates on endometriosis, lung cancer screening, and HDL-C; Sinclair’s fasting episode; Johnson’s Immortals RX prescription-drug pivot; and Patrick’s practical guidance on movement, sleep, diet quality, and supplements.

View full content archiveDiscover more channels